A NIS gene delivered with an adenovirus vector and a tissue-specific gene promoter, the prostate-specific antigen gene (PSA) promoter, conferred efficient functional NIS expression in prostate cancer xenografts[79,80]. This evidence concerns the gene SLC5A5 and prostate cancer.